₹5,563
▼ -146.15 -2.56%
18 Jul 2026
NSE Listed
Alkem Laboratories Ltd. (ALKEM)
Volume: 67,610Avg Vol 1W: 2,25,047.8Avg Vol 1M: 2,31,951.2552W Range:₹4,738.5₹5,933.5
Key Ratios
Checked 21h agoMarket Cap₹67,381 Cr
Current Price₹5,563
Previous Close₹5,709.15
High / Low (52w)₹5,933.5 / ₹4,738.5
Volume67,610
Avg Vol (1W)2,25,047.8
Avg Vol (1M)2,31,951.25
Stock P/E25.58
Book Value₹1,030.68
Dividend Yield—
ROE19.9%
ROA—
Revenue (TTM)₹13,458 Cr
Revenue Growth—
Profit Margin—
Total Debt₹311 Cr
Shares Outstanding—
Face Value₹2
EPS (TTM)₹190.79
P/B4.73
Debt / Equity0.06
50 DMA₹5,454.77
200 DMA₹5,534.27
Day change-2.56%
Price Chart
₹5,563▲ 10.85% · 1Y
2025-07-172026-07-16
20-day avg volume: 2.3L shares
Pros
- Healthy return on equity of 19.9%.
- Company is almost debt-free.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3,032 Cr | ₹3,415 Cr | ₹3,374 Cr | ₹3,144 Cr | ₹3,371 Cr | ₹4,001 Cr | ₹3,737 Cr | ₹3,603 Cr |
| EBITDA | ₹648 Cr | ₹808 Cr | ₹767 Cr | ₹425 Cr | ₹788 Cr | ₹931 Cr | ₹876 Cr | ₹612 Cr |
| Net Profit | ₹545 Cr | ₹689 Cr | ₹626 Cr | ₹306 Cr | ₹664 Cr | ₹765 Cr | ₹636 Cr | ₹236 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹6,517 Cr | ₹7,445 Cr | ₹8,449 Cr | ₹9,098 Cr | ₹10,797 Cr | ₹11,815 Cr | ₹12,978 Cr | ₹13,458 Cr |
| EBITDA | ₹981 Cr | ₹1,009 Cr | ₹1,325 Cr | ₹1,901 Cr | ₹1,912 Cr | ₹1,515 Cr | ₹2,257 Cr | ₹2,649 Cr |
| Net Profit | ₹631 Cr | ₹761 Cr | ₹1,127 Cr | ₹1,585 Cr | ₹1,646 Cr | ₹984 Cr | ₹1,796 Cr | ₹2,165 Cr |
| EPS | 52.77 | 63.61 | 94.26 | 132.57 | 137.63 | 82.31 | 150.19 | 181.11 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹7,666 Cr | ₹8,208 Cr | ₹9,946 Cr | ₹11,519 Cr | ₹14,069 Cr | ₹13,757 Cr | ₹15,575 Cr | ₹17,691 Cr |
| Total Liabilities | ₹2,680 Cr | ₹2,636 Cr | ₹3,637 Cr | ₹3,961 Cr | ₹5,222 Cr | ₹4,322 Cr | ₹4,861 Cr | ₹5,257 Cr |
| Equity | ₹4,985 Cr | ₹5,572 Cr | ₹6,309 Cr | ₹7,558 Cr | ₹8,847 Cr | ₹9,435 Cr | ₹10,714 Cr | ₹12,434 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹469 Cr | ₹1,029 Cr | ₹868 Cr | ₹1,666 Cr | ₹1,508 Cr | ₹1,956 Cr | ₹2,355 Cr | ₹2,417 Cr |
| Investing | ₹-357 Cr | ₹-314 Cr | ₹-741 Cr | ₹-999 Cr | ₹-1,435 Cr | ₹113 Cr | ₹-1,008 Cr | ₹-1,299 Cr |
| Financing | ₹85 Cr | ₹-379 Cr | ₹79 Cr | ₹-272 Cr | ₹380 Cr | ₹-1,761 Cr | ₹-1,145 Cr | ₹-811 Cr |
| Free Cash Flow | ₹469 Cr | ₹1,029 Cr | ₹868 Cr | ₹1,666 Cr | ₹1,508 Cr | ₹1,956 Cr | ₹2,355 Cr | ₹2,417 Cr |
Shareholding
Promoter 49.7% Institutions 33.05% Public 17.25%
Efficiency & Working Capital
ROCE20%
Interest Coverage21.8
Dividend Payout—
Debtor Days69 d
Inventory Days82 d
Payable Days52 d
Cash Conversion Cycle100 d
Working Capital Days152 d
Shareholding Details
As of 2026-06-30
Promoter49.7%
FII10.4%
DII22.6%
Institutions33%
Public17.3%
Promoter Pledge0%
No. of Shareholders62,822
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 56.7% | 56.7% | 56.7% | 56.4% | 55.7% | 55.7% | 55.1% | 53% | 51.2% | 51.2% | 51.2% | 49.7% |
| FIIs | 6% | 8.5% | 9.1% | 8.7% | 9% | 10.1% | 9.4% | 9.1% | 9.5% | 10% | 10.2% | 10.4% |
| DIIs | 17.6% | 14.9% | 15.6% | 18.6% | 19.2% | 18% | 19.4% | 21.8% | 21.9% | 21.5% | 21.4% | 22.6% |
| Public | 19.6% | 19.8% | 18.5% | 16.4% | 16.1% | 16.2% | 16% | 16.1% | 17.4% | 17.3% | 17.2% | 17.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 69,442 | 65,184 | 65,830 | 69,627 | 74,744 | 84,038 | 84,326 | 79,740 | 67,196 | 64,536 | 62,835 | 62,822 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sarandhar Singh * (please Refer Notes) | Shareholding of Promoter and Promoter Group | 18.3% | 2.19 Cr |
| Basudeo Narain Singh | Shareholding of Promoter and Promoter Group | 7.3% | 86,95,360 |
| Mritunjay Kumar Singh | Shareholding of Promoter and Promoter Group | 6.4% | 76,82,000 |
| Madhurima Singh& (please Refer Notes) | Shareholding of Promoter and Promoter Group | 6.2% | 73,93,939 |
| Hdfc Mutual Fund - Hdfc Mid-cap Fund | Public Shareholding | 4.8% | 57,06,750 |
| Icici Prudential Multi-asset Fund | Public Shareholding | 3.6% | 42,68,472 |
| Madhurima Singh@ (please Refer Notes) | Shareholding of Promoter and Promoter Group | 2.6% | 30,92,875 |
| Kishor Kumar Singh | Public Shareholding | 2.5% | 29,73,312 |
| Alok Kumar | Public Shareholding | 2.3% | 27,64,719 |
| Ashok Kumar | Public Shareholding | 2.3% | 26,88,000 |
| Seema Singh | Shareholding of Promoter and Promoter Group | 2.2% | 25,79,045 |
| Deepak Kumar Singh | Public Shareholding | 2% | 24,02,140 |
| Archana Singh | Shareholding of Promoter and Promoter Group | 2% | 23,94,050 |
| Sbi Large & Midcap Fund | Public Shareholding | 2% | 23,83,162 |
| Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap Fund | Public Shareholding | 1.9% | 22,34,434 |
| Dsp Midcap Fund | Public Shareholding | 1.8% | 21,32,118 |
| Nps Trust- A/c Hdfc Pension Fund Management Limited Scheme E - Tier I | Public Shareholding | 1.5% | 17,41,075 |
| Life Insurance Corporation Of India - P & Gs Fund | Public Shareholding | 1.4% | 17,15,063 |
| Rajesh Kumar | Public Shareholding | 1.4% | 16,84,535 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 1.3% | 15,60,875 |
| Rajeev Ranjan | Public Shareholding | 1.2% | 14,85,342 |
| Aniruddha Singh& (please Refer Notes) | Shareholding of Promoter and Promoter Group | 1% | 12,08,971 |
| Divya Singh& (please Refer Notes) | Shareholding of Promoter and Promoter Group | 1% | 12,08,971 |
| Meghna Singh | Shareholding of Promoter and Promoter Group | 1% | 12,08,650 |
| Shrey Shree Anant Singh | Shareholding of Promoter and Promoter Group | 1% | 11,95,650 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Sarandhar Singh * (please Refer Notes) | 0 | 0% | 2026-06-30 |
| Basudeo Narain Singh | 0 | 0% | 2026-06-30 |
| Mritunjay Kumar Singh | 0 | 0% | 2026-06-30 |
| Madhurima Singh& (please Refer Notes) | 0 | 0% | 2026-06-30 |
| Madhurima Singh@ (please Refer Notes) | 0 | 0% | 2026-06-30 |
| Seema Singh | 0 | 0% | 2026-06-30 |
| Archana Singh | 0 | 0% | 2026-06-30 |
| Aniruddha Singh& (please Refer Notes) | 0 | 0% | 2026-06-30 |
| Divya Singh& (please Refer Notes) | 0 | 0% | 2026-06-30 |
| Meghna Singh | 0 | 0% | 2026-06-30 |
| Shrey Shree Anant Singh | 0 | 0% | 2026-06-30 |
| Raj Kumar Singh | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Basudeo N Singh | Executive Chairman | 2025 |
| SANDEEP SINGH | Managing Director | 2025 |
| Mritunjay Kumar Singh | Executive Director | 2025 |
| Manish Narang | Company Sec. & Compli. Officer | 2025 |
| Narendra Aneja | Independent Director | 2025 |
| SARVESH SINGH | Executive Director | 2025 |
| Madhurima Singh | Executive Director | 2025 |
| Sujjain Talwar | Independent Director | 2025 |
| Srinivas Singh | Executive Director | 2025 |
| Rajeev Kher | Independent Director | 2025 |
| Ranjal Laxmana Shenoy | Independent Director | 2025 |
| Neela Bhattacherjee | Independent Director | 2025 |
| Diwakar Gupta | Independent Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharma Business | ₹2,708 Cr | 100% |
| Others (Investing & Real Estate) | ₹0 Cr | 0% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹6,315 Cr | 71.6% |
| United States of America | ₹1,672 Cr | 19% |
| Other Countries | ₹827 Cr | 9.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 50 | 24 | 24 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-02-20 | ₹43 (2150%) | Interim |
| dividend | 2025-08-08 | ₹8 (400%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 4,649 | 139 | 0 | 186 | 0 | 5,056 |
| 2025 | 1,667 | 0 | 0 | 0 | 0 | 1,667 |
| 2025 | 3 | 0 | 0 | 0 | 0 | 3 |
Insider / Designated-Person Trades
17 recent disclosure(s)
Mr. Deepak Kumar SinghDisposal · 25,000
Mritunjay Kumar SinghAcquisition · 1,643
Mritunjay Kumar SinghAcquisition · 3,357
Dhananjay and Madhurima Singh TrustAcquisition · 1,050
Dhananjay and Madhurima Singh TrustAcquisition · 2,000
Mr. Deepak Kumar SinghDisposal · 2,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Market04/06/2025 · 8,70,228
Company Information
Incorporated1973
ChairmanBasudeo N Singh
AuditorDeloitte Haskins & Sells LLP/B S R & Co LLP
Investor Email[email protected] ; [email protected]
📍 Alkem House SenapatiBapat Marg, Lower Parel, Mumbai, Maharashtra, 400013
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search